Education
About Us
Working with TipRanks
Follow Us
Pediatrix Medical Group (MD)
NYSE:MD
Total Valuation
Pediatrix Medical Group has a market cap or net worth of $1.62B. The enterprise value is $1.97B.
Market Cap$1.62B
Enterprise Value$1.97B
Share Statistics
Pediatrix Medical Group has 83,001,076 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding83,001,076
Owned by Insiders1.22%
Owned by Institutions9.09%
Financial Efficiency
Pediatrix Medical Group’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 9.67%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)9.67%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee464.53K
Profits Per Employee0.00
Employee Count4,120
Asset Turnover0.85
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Pediatrix Medical Group is 10.1. Pediatrix Medical Group’s PEG ratio is -0.04.
PE Ratio10.1
PS Ratio0.95
PB Ratio2.11
Price to Fair Value2.11
Price to FCF7.22
Price to Operating Cash Flow6.15
PEG Ratio-0.04
Income Statement
In the last 12 months, Pediatrix Medical Group had revenue of 1.91B and earned 165.39M in profits. Earnings per share was 1.94.
Revenue1.91B
Gross Profit471.88M
Operating Income231.09M
Pretax Income216.43M
Net Income165.39M
EBITDA274.22M
Earnings Per Share (EPS)1.94
Cash Flow
In the last 12 months, operating cash flow was 271.09M and capital expenditures -18.46M, giving a free cash flow of 252.63M billion.
Operating Cash Flow271.09M
Free Cash Flow252.63M
Free Cash Flow per Share3.04
Dividends & Yields
Pediatrix Medical Group pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.56
52-Week Price Change35.30%
50-Day Moving Average21.32
200-Day Moving Average17.84
Relative Strength Index (RSI)39.27
Average Volume (3m)781.42K
Important Dates
Pediatrix Medical Group upcoming earnings date is Apr 30, 2026, Before Open (Confirmed).
Last Earnings DateFeb 19, 2026
Next Earnings DateApr 30, 2026
Ex-Dividend Date―
Financial Position
Pediatrix Medical Group as a current ratio of 1.66, with Debt / Equity ratio of 76.26%
Current Ratio1.66
Quick Ratio1.66
Debt to Market Cap0.35
Net Debt to EBITDA1.04
Interest Coverage Ratio6.43
Taxes
In the past 12 months, Pediatrix Medical Group has paid 51.04M in taxes.
Income Tax51.04M
Effective Tax Rate0.24
Enterprise Valuation
Pediatrix Medical Group EV to EBITDA ratio is 7.69, with an EV/FCF ratio of 8.35.
EV to Sales1.10
EV to EBITDA7.69
EV to Free Cash Flow8.35
EV to Operating Cash Flow7.78
Balance Sheet
Pediatrix Medical Group has $499.72M in cash and marketable securities with $660.30M in debt, giving a net cash position of -$160.58M billion.
Cash & Marketable Securities$499.72M
Total Debt$660.30M
Net Cash-$160.58M
Net Cash Per Share-$1.93
Tangible Book Value Per Share-$4.83
Margins
Gross margin is 25.50%, with operating margin of 12.07%, and net profit margin of 8.64%.
Gross Margin25.50%
Operating Margin12.07%
Pretax Margin11.31%
Net Profit Margin8.64%
EBITDA Margin14.33%
EBIT Margin13.19%
Analyst Forecast
The average price target for Pediatrix Medical Group is $20.67, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$20.67
Price Target Upside4.71% Upside
Analyst ConsensusHold
Analyst Count5
Revenue Growth Forecast-4.21%
EPS Growth Forecast―